z-logo
open-access-imgOpen Access
Correction: Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin
Author(s) -
Sungjin Chung,
Soojeong Kim,
Min-Young Kim,
Eun Sil Koh,
Seok Joon Shin,
Cheol Whee Park,
Yoon Sik Chang,
HoShik Kim
Publication year - 2018
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0196885
Subject(s) - aliskiren , medicine , blockade , urology , paricalcitol , pharmacology , renin–angiotensin system , blood pressure , secondary hyperparathyroidism , receptor , parathyroid hormone , calcium

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom